From: Stock Gumshoe<[email protected]>
Subject: Checking in on cancer with Doc Gumshoe
Preheader: Michael's latest
Reply: [email protected]
You're receiving this email newsletter because you, or someone using [email protected], signed up for the Stock Gumshoe Daily Update. Please unsubscribe if you don't want Stock Gumshoe emails (this will not cancel membership, just stop emails). 

DAILY UPDATE
October 8, 2018
email formatted funny? Web version
Dear Valued Reader,

I'm back after a few days of field-trip chaperoning, but am finishing up the overdue Friday File for our favorite people (you know who you are!)... so for today's missive I turn you over to Doc Gumshoe, who's got an update on where we are in the world of cancer research and progress (or lack thereof).  Anyone who invests in biotechs that hope to cure cancer should understand the general landscape and some of the science, of course, as should anyone whose life is touched by cancer... and that's pretty much everyone, so just read it already...


A little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom. Because a game-changing deal just went down and that company now has the opportunity to rake in profits...

We here at The Motley Fool are convinced we’re only in the VERY early days of this company’s trajectory.

Find out now.


Advertisement

There's been a lot of discussion at Stock Gumshoe about the latest wave of "special report" ads from the Motley Fool, including one that talks up a "tiny black box that could eliminate cable" and another one that's a play on "cable TV's ticking time bomb" ... so I thought I'd dig in and make sure we have some clarity and some decent Thinkolator answers about these world-changing stocls... so what's the story? Just click here for that one.

Quite a few of my internet friends sent along questions about this "first trillion dollar patent" that Matt McCall is saying will "release the largest royalty payments ever known" ... perhaps because they  know I'm a sucker for royalties (and any other lazy investment, frankly).  So what's he pitching, and should we be getting excited?  Just click below to...


Disclaimer: Nothing in this email or in the linked articles should be considered to be individual investment advice -- we can't tell you what you should do with your money, we can just share our opinions and perspective. Our authors try to use reliable information sources but also make mistakes of both fact and judgement on occasion, so all assertions should be checked and confirmed. You should speak with your financial advisor and understand everything fully before committing money to any investment.

Most issues of this email newsletter include advertising, and it should not be assumed that the presence of an advertisement means that the product or service advertised is endorsed by Stock Gumshoe or the author. For full disclaimers, disclosure information, and privacy policies please see the prominent links at the bottom of each page at StockGumshoe.com.

If you wish to unsubscribe to these mailings, there are links at both the bottom and top of this email that you can use to do so permanently and safely, we have no wish to email people who don't want to receive these messages. Please note that unsubscribing using the link below applies only to receiving emails, if you are a member of the Stock Gumshoe Irregulars that membership will not automatically change or be canceled. Please contact us if you need to change a paid membership.
Unsubscribe
Stock Gumshoe, 351 Pleasant St., Suite B #205, Northampton, MA 01060